Your 1.7mg Monthly Cost Journey Explained
Can I Start Wegovy at 1.7mg? Understanding Your Monthly Cost Position
The question "can I start Wegovy at 1.7mg" typically arises when patients are planning their ongoing monthly costs or returning after a treatment break. This dose, priced at £139.99 monthly, sits at weeks 13-16 of the escalation schedule - a critical juncture where many patients experience their most significant results. Unlike starting doses, the 1.7mg strength represents substantial investment in your weight management journey, making monthly cost planning essential.
For patients asking "can I start Wegovy at 1.7mg" from a cost perspective, this dose bridges the gap between the earlier escalation phases and your maintenance investment. At £139.99, it's notably more than the 1mg dose (£99.99) but significantly less than the 2.4mg maintenance dose (£209.99). This positioning makes the 1.7mg phase crucial for budget preparation as you approach long-term treatment costs.
Monthly Cost Breakdown: Why Patients Choose 1.7mg Wegovy Strategically
Understanding whether you can start Wegovy at 1.7mg requires examining the complete monthly cost trajectory across the 16-week escalation. The journey begins at £79.99 (0.25mg, weeks 1-4), progresses to £94.99 (0.5mg, weeks 5-8), continues to £99.99 (1mg, weeks 9-12), before reaching your current consideration at £139.99 (1.7mg, weeks 13-16). This systematic increase prepares patients financially for the £209.99 monthly maintenance cost at 2.4mg.
When patients ask "can I start Wegovy at 1.7mg" they're often planning their annual treatment investment. At maintenance dose, expect £209.99 monthly, totaling approximately £2,520 annually. The 1.7mg phase at £139.99 provides a stepping stone to this commitment, with our DOSE25 discount code ensuring returning customers access the most competitive pricing available in the UK market.
Clinical Evidence Supporting Wegovy 1.7mg Treatment Decisions
Research from the STEP clinical trial programme demonstrates that dose escalation through 1.7mg is crucial for optimal outcomes. In the landmark STEP 1 trial published by Wilding et al. in the New England Journal of Medicine (2021), patients following the complete escalation protocol experienced approximately 15% average weight loss at 68 weeks. The 1.7mg dose represents a critical phase where therapeutic effects typically accelerate.
For patients considering "can I start Wegovy at 1.7mg," clinical data suggests that proper dose escalation optimises both efficacy and tolerability. The STEP trials consistently showed that patients who completed the full escalation schedule, including the 1.7mg phase, achieved superior weight management outcomes compared to those who abbreviated their progression.
How Wegovy 1.7mg Works: GLP-1 Mechanism at Higher Dosing
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. At the 1.7mg dose strength, this prescription-only medicine provides enhanced appetite reduction and prolonged satiety compared to lower doses. The mechanism targets brain appetite centres, helping reduce food cravings while promoting feeling of fullness after smaller meals. This higher dosing typically produces more pronounced effects on portion control and between-meal hunger. For patients asking "can I start Wegovy at 1.7mg," understanding this enhanced mechanism helps justify the £139.99 monthly investment in stronger appetite regulation.
Ordering Process: Getting Your 1.7mg Wegovy Supply
Accessing Wegovy 1.7mg through EverydayMeds begins with our 3-minute online clinical assessment, designed to verify your suitability for this higher dose strength. Our UK-registered prescribers review your assessment within 3 working days (express 24-hour service available), ensuring appropriate medical oversight for this prescription-only medicine. Once approved, we dispatch your genuine Novo Nordisk Wegovy via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements throughout transit. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance and authentic medication supply. The process includes clear dosing instructions and ongoing support for your £139.99 monthly treatment.
Storage and Practical Considerations for 1.7mg Wegovy
Your 1.7mg Wegovy FlexTouch pen requires refrigeration at 2-8°C before first use, though it can tolerate room temperature below 30°C for up to 6 weeks once removed from the fridge. This storage flexibility makes the £139.99 monthly investment practical for travel and daily life. The pre-filled pen delivers exactly 1.7mg in a simple once-weekly injection, typically administered on the same day each week. Dose escalation from 1mg to 1.7mg should follow the prescribed 4-week intervals, as skipping escalation steps may increase side effects. Patients asking "can I start Wegovy at 1.7mg" should understand this represents weeks 13-16 of a structured 16-week programme.
Long-term Cost Planning: 1.7mg as Your Pre-Maintenance Phase
The strategic question "can I start Wegovy at 1.7mg" often reflects sophisticated cost planning for long-term weight management. This dose serves as the final stepping stone before committing to £209.99 monthly maintenance costs, allowing patients to assess their response before the larger financial commitment. Many patients use the 1.7mg phase to evaluate whether the therapeutic benefits justify progressing to 2.4mg maintenance dosing.
Our Elevate Duo bundle (1.7mg + 2.4mg) at £369.99 provides seamless transition planning, covering both your current 1.7mg phase and first maintenance dose. This bundling approach helps manage the cost transition while ensuring uninterrupted treatment supply as you progress from £139.99 to £209.99 monthly investment.
Secure Your 1.7mg Wegovy Supply with Confidence
For patients ready to answer "can I start Wegovy at 1.7mg" with action, EverydayMeds provides the UK's most straightforward access to genuine Novo Nordisk Wegovy. Use code DOSE25 at checkout to secure your £139.99 monthly rate, with returning customer benefits that maintain competitive pricing throughout your treatment journey. Our clinical assessment ensures appropriate prescribing oversight, while next-day delivery commitment reliable supply for your ongoing weight management programme. Visit our dedicated 1.7mg product page to begin your clinical assessment today. Order with confidence from the UK's leading weight management pharmacy, fully registered with the GPhC (#9012878) and committed to your long-term treatment success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
